Lung Cancer-Related Mortality With Inhaled Insulin or a Comparator: Follow-Up Study of patients previously enrolled in Exubera Controlled Clinical Trials (FUSE) Final Results

The Follow-Up Study of patients previously enrolled in Exubera controlled clinical trials (FUSE) was designed to evaluate whether patients previously treated with Exubera (EXU; insulin human [rDNA origin], inhaled powder) in controlled clinical trials died because of incident primary lung cancer at...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2019-09, Vol.42 (9), p.1708-1715
Hauptverfasser:	Gatto, Nicolle M, Koralek, Daniel O, Bracken, Michael B, Duggan, William T, Lem, Joanna, Klioze, Sol, Koch, Gary G, Wise, Robert A, Cohen, Roger B, Jackson, Neville C
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Inhalation Adult Clinical trials Cohort Studies Density ratio Diabetes mellitus Diabetes Mellitus - drug therapy Diabetes Mellitus - mortality Fatalities Female Follow-Up Studies Health risk assessment Health risks Humans Hypoglycemic Agents - adverse effects Incidence Insulin Insulin - adverse effects Insulin, Regular, Human - adverse effects Lung cancer Lung Neoplasms - chemically induced Lung Neoplasms - mortality Male Middle Aged Mortality Powder Prospective Studies Randomization Randomized Controlled Trials as Topic Research design
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!